Improve the quality of human life.
Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle-based drug development with breakthrough small molecule and biological therapeutics, Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life.
|Health Care Equipment and Services||Operating|
Funding and Financing Rounds
Series C + / Equity / PRI
Impact Reports & Metrics
419 Davis Drive, Suite 100
Morrisville, North Carolina 27560
United States of America